Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lexicon Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lexicon Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Debbane Raymond | Director | 1,995,498 | Jun 4, 2026 | 7 |
| Sobecki Christopher J | Director | 293,177 | Jun 4, 2026 | 2 |
| Barker Sam L | Director | 213,771 | Jun 4, 2026 | 2 |
| Amouyal Philippe | Director | 374,486 | Jun 4, 2026 | 2 |
| Swain Judith L | Director | 174,486 | Jun 4, 2026 | 2 |
| Sullivan Diane E. | Director | 126,122 | Jun 4, 2026 | 2 |
| Cheung Ivan | Director | 89,312 | Jun 4, 2026 | 2 |
| Artal Group S.A. | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 3 |
| Artal International S.C.A. | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 3 |
| Westend S.A. | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 3 |
| Stichting Administratiekantoor Westend | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 3 |
| Artal International Management S.A. | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 3 |
| Wittouck Amaury | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 2 |
| Artal Participations S.a r.l. | Director, 10% Owner | 175,156,062Indirect | May 8, 2026 | 3 |
| Coiante Scott M | SVP, Chief Financial Officer | 105,356 | Mar 3, 2026 | 2 |
| Crum Brian T | SVP, General Counsel & Secr. | 428,802 | Mar 3, 2026 | 2 |
| DeFrancesco Lisa | SVP, IR and Corp Comm | 93,869 | Mar 3, 2026 | 2 |
| Granowitz Craig B | SVP, Chief Medical Officer | 323,430 | Mar 3, 2026 | 2 |
| McDermott Wendy | SVP, Human Resources | 277,945 | Mar 3, 2026 | 2 |
| Exton Michael | Chief Executive Officer | 298,432 | Mar 3, 2026 | 2 |
| Gopinathan Suma | SVP, Discovery | 150,132 | Mar 3, 2026 | 2 |
| Martens Rachel Yap | SVP, Partnerships & Corp Strat | 31,264 | Mar 3, 2026 | 2 |
| Siren, L.L.C. | Director, 10% Owner | 367,145Indirect | Feb 4, 2026 | 1 |
| Invus Global Management, LLC | Director, 10% Owner | 367,145Indirect | Feb 4, 2026 | 1 |
| Main Alan J | EVP, Innov & Chem Sciences | 339,104 | Mar 3, 2025 | 0 |
| Alexander Kristen | VP, Finance and Accounting | 76,368 | Mar 3, 2025 | 0 |
| Corrigan Brian | SVP, Regulatory & QA | – | Feb 18, 2025 | 0 |
| Wade Jeffrey L | President and COO | 324,214 | Jul 8, 2024 | 0 |
| Invus Public Equities Advisors, LLC | Director, 10% Owner | 136,180,481Indirect | May 14, 2024 | 0 |
| Invus Public Equities, L.P. | Director, 10% Owner | 136,180,481Indirect | May 14, 2024 | 0 |
| Invus Advisors, L.L.C. | Director, 10% Owner | 136,180,481Indirect | May 14, 2024 | 0 |
| Invus, L.P. | Director, 10% Owner | 136,180,481Indirect | May 14, 2024 | 0 |
| Lefkowitz Robert J MD | Director | 48,364 | May 13, 2024 | 0 |
| Coats Lonnel | Chief Executive Officer | 1,098,068 | Feb 29, 2024 | 0 |
| Kassler-Taub Kenneth B. | SVP, Regulatory & QA | 162,672 | Feb 29, 2024 | 0 |
| Garner Thomas | SVP, Chief Commercial Officer | – | Feb 12, 2024 | 0 |
| Nies Alan S | Director | 41,046 | May 22, 2023 | 0 |
| Palantoni Frank | Director | 40,332 | May 22, 2023 | 0 |
| Seth Kiernan | VP, Chief Commercial Officer | 53,136 | Mar 1, 2023 | 0 |
| Ulys, L.L.C. | Director, 10% Owner | 5,451,204Indirect | Aug 9, 2022 | 0 |
| Invus US Partners LLC | Director, 10% Owner | 5,451,204Indirect | Aug 9, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 (view filing) | Feb 25 | 2 days | Debbane RaymondDirector | PPurchase | +2.00K | $1.49 | +$2.98K | +0.1%1.91M after | |
| Feb 25, 2026 (view filing) | Feb 23 | 2 days | Debbane RaymondDirector | PPurchase | +100.0K | $1.47 | +$147.0K | +5.5%1.90M after | |
| Feb 23, 2026 (view filing) | Feb 19-20 | 4 days | Debbane RaymondDirector | PPurchase | +150.0K | $1.47 | +$220.0K | +9.1%1.80M after | 2 lots |
| Feb 18, 2026 (view filing) | Feb 13-18 | 5 days | Debbane RaymondDirector | PPurchase | +268.5K | $1.31 | +$353.1K | +19.4%1.65M after | 3 lots |
| Feb 4, 2026 (view filing)4:25 PM ET | Feb 2 | 2 days | Debbane Raymond and 8 othersDirector | PPurchase | +1.54M | $1.30 | +$2.00M | New position1.54M after | |
| Nov 17, 2023 (view filing) | Nov 16 | 1 day | Coats LonnelChief Executive Officer | PPurchase | +90.0K | $1.05 | +$94.5K | +10.9%914.4K after | |
| Nov 14, 2023 (view filing) | Nov 13 | 1 day | Amouyal PhilippeDirector | PPurchase | +200.0K | $1.01 | +$202.0K | +495.9%240.3K after | |
| Nov 13, 2023 (view filing) | Nov 10 | 3 days | Coats LonnelChief Executive Officer | PPurchase | +10.0K | $1.01 | +$10.1K | +1.2%824.4K after | |
| Oct 12, 2023 (view filing) | Oct 10-12 | 2 days | Debbane RaymondDirector | PPurchase | +1.00M | $1.10 | +$1.10M | +293.4%1.34M after | 3 lots |
| Sep 14, 2023 (view filing) | Sep 14 | Same day | Wade Jeffrey LPresident and CFO | PPurchase | +10.0K | $1.38 | +$13.8K | +3.9%264.3K after | |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | McDermott WendyVP, Human Resources | PPurchase | +6.00K | $1.84 | +$11.0K | +26.7%28.5K after | |
| Jun 29, 2023 (view filing) | Jun 29 | Same day | Coats LonnelChief Executive Officer | PPurchase | +10.0K | $2.16 | +$21.6K | +1.2%814.4K after | |
| Jun 27, 2023 (view filing) | Jun 23 | 4 days | McDermott WendyVP, Human Resources | PPurchase | +10.0K | $2.43 | +$24.3K | +80.1%22.5K after | |
| Jun 26, 2023 (view filing) | Jun 23-26 | 3 days | Coats LonnelChief Executive Officer | PPurchase | +20.0K | $2.34 | +$46.8K | +2.5%804.4K after | 2 lots |
| Jun 22, 2023 (view filing) | Jun 22 | Same day | Coats LonnelChief Executive Officer | PPurchase | +40.0K | $2.31 | +$92.4K | +5.4%784.4K after | |
| Jun 20, 2023 (view filing) | Jun 20 | Same day | Wade Jeffrey LPresident and CFO | PPurchase | +12.0K | $2.34 | +$28.1K | +5.0%254.3K after | 2 lots |
| Jun 5, 2023 (view filing)4:46 PM ET | Jun 5 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +27.8M | $2.60 | +$72.2M | +54.6%78.6M after | |
| Aug 9, 2022 (view filing)4:48 PM ET | Aug 5 | 4 days | Debbane Raymond and 2 othersDirector, 10% Owner | PPurchase | +147.4K | $2.50 | +$368.5K | +2.8%5.45M after | |
| Aug 9, 2022 (view filing)4:46 PM ET | Aug 5 | 4 days | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +2.43M | $2.50 | +$6.07M | +5.0%50.9M after | |
| Aug 1, 2022 (view filing)4:15 PM ET | Aug 1 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +16.2M | $2.50 | +$40.4M | +50.1%48.4M after | |
| Aug 1, 2022 (view filing)4:15 PM ET | Aug 1 | Same day | Debbane Raymond and 2 othersDirector, 10% Owner | PPurchase | +982.6K | $2.50 | +$2.46M | +22.7%5.30M after | Duplicate filing |
| Aug 1, 2022 (view filing) | Aug 1 | Same day | Debbane RaymondDirector | PPurchase | +982.6K | $2.50 | +$2.46M | +22.7%5.30M after |